Novavax begins phase three trial for Covid vaccine

Novavax will be the latest company to begin phase three of its vaccine trial. The trial will have up to 30,000 volunteers enrolled across approximately 115 sites in the U.S. and Mexico. CNBC's "Squawk on the Street" crew discuss.
Mon, Dec 28 20209:26 AM EST